Valuation Sanofi

Stocks

Real-time Euronext Paris Other stock markets 08:16:05 2026-06-09 am EDT			5-day change	1st Jan Change
76.89 ^EUR	+0.29%		+4.71%	-7.06%

07:57am	Kymera Therapeutics Unlocks $20 Million Milestone After Dosing First Participant in KT-485 Phase 1 Trial	MT
04:11am	SANOFI : Deutsche Bank remains its Buy rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	92,021	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-8.58%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	104,282	102,419	101,712
Change	-	-1.71%	1.04%	4.49%	-11.2%	-6.61%	-1.79%	-0.69%
P/E ratio	17.8x	16.7x	20.8x	20.4x	12.9x	11.2x	10.5x	9.08x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.22x	1.16x	1.09x
PEG	-	2.07x	-1.1x	3.14x	0.3x	1.63x	1.61x	0.6x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.96x	1.84x	1.76x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.22x	2.05x	1.94x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	7.23x	6.71x	6.1x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	8.02x	7.4x	6.7x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	12.1x	11.2x	9.92x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.24%	8.92%	10.1%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.281	4.523	4.847
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.58%	5.9%	6.32%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.841	7.286	8.439
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	62.6%	62.1%	57.4%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,045	49,942	52,421
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,415	15,256	16,671
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,003	13,839	15,183
Net income ¹	6,223	6,720	5,400	5,744	7,813	8,134	8,935	10,336
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	12,262	10,398	9,691
Reference price ²	88.58	89.84	89.76	93.74	82.72	76.67	76.67	76.67
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,200,220	-	-
Announcement Date	2/4/22	2/3/23	2/1/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SANOFI	11.21x	2.22x	7.23x	5.58%	106B
ELI LILLY AND COMPANY	33.62x	12.22x	25.16x	0.59%	1,025B
JOHNSON & JOHNSON	24.81x	5.72x	15.56x	2.3%	559B
ABBVIE INC.	27.31x	6.66x	13.61x	3.08%	394B
ROCHE HOLDING AG	17.31x	4.28x	10.51x	3.11%	324B
MERCK & CO., INC.	53.32x	4.96x	20.16x	2.8%	295B
ASTRAZENECA PLC	23.32x	4.83x	13.75x	1.81%	286B
NOVARTIS AG	20.51x	5.3x	12.89x	3.08%	270B
NOVO NORDISK A/S	12.03x	4.53x	9.26x	4.17%	186B
AMGEN INC.	22.48x	6.03x	10.53x	2.92%	187B
Average	24.59x	5.67x	13.87x	2.94%	363.25B
Weighted average by Cap.	27.61x	7.22x	16.81x	2.26%